Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy

被引:3
作者
Medeot, Marta [1 ]
Tiribelli, Mario [1 ]
Patriarca, Francesca [1 ]
Sperotto, Alessandra [1 ]
Geromin, Antonella [1 ]
Fanin, Renato [1 ]
机构
[1] Azienda Osped Univ Udine, Div Hematol & Bone Marrow Transplantat, Dept Clin & Expt Med Sci, I-33100 Udine, Italy
关键词
CHEMOTHERAPY;
D O I
10.1002/ajh.23769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:933 / 934
页数:2
相关论文
共 4 条
  • [1] Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia
    Craddock, C.
    Labopin, M.
    Pillai, S.
    Finke, J.
    Bunjes, D.
    Greinix, H.
    Ehninger, G.
    Steckel, N-K
    Zander, A. R.
    Schwerdtfeger, R.
    Buchholz, S.
    Kolb, H-J
    Volin, L.
    Fauser, A.
    Polge, E.
    Schmid, C.
    Mohty, M.
    Rocha, V.
    [J]. LEUKEMIA, 2011, 25 (05) : 808 - 813
  • [2] Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy
    Jabbour, Elias
    Daver, Naval
    Champlin, Richard
    Mathisen, Michael
    Oran, Betul
    Ciurea, Stefan
    Khouri, Issa
    Cornelison, A. Megan
    Ghanem, Hady
    Cardenas-Turanzas, Marylou
    Popat, Uday
    Ravandi, Farhad
    Giralt, Sergio
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    de Lima, Marcos
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 395 - 398
  • [3] Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy
    Ravandi, Farhad
    Cortes, Jorge
    Faderl, Stefan
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Santos, Fabio P. S.
    Shan, Jianqin
    Brandt, Mark
    de Lima, Marcos
    Pierce, Sherry
    Kantarjian, Hagop
    [J]. BLOOD, 2010, 116 (26) : 5818 - 5823
  • [4] The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo
    Todisco, E.
    Ciceri, F.
    Oldani, E.
    Boschini, C.
    Mico, C.
    VanLint, M. T.
    Donnini, I.
    Patriarca, F.
    Alessandrino, P. E.
    Bonifazi, F.
    Arcese, W.
    Barberi, W.
    Marenco, P.
    Terruzzi, E.
    Cortelazzo, S.
    Santarone, S.
    Proia, A.
    Corradini, P.
    Tagliaferri, E.
    Falcioni, S.
    Irrera, G.
    Dallanegra, L.
    Castagna, L.
    Santoro, A.
    Camboni, A.
    Sacchi, N.
    Bosi, A.
    Bacigalupo, A.
    Rambaldi, A.
    [J]. LEUKEMIA, 2013, 27 (10) : 2086 - 2091